| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.002 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.096 | 0.003 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |